1Hurwitz JL, Mccoy F, Scullin P, et al. New advances in the second-line treatment of small cell lung cancer. Oncologist, 2009, 14(10): 986-994.
2Puglisi M, Dolly S, Faria A, et al. Treatment options for small cell lung cancer: do we have more choice? BrJ Cancer, 2010, 102(4): 629-638.
3Lababede O, Meziane M, Rice T. Seventh edition of the cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams. Chest, 2011,139(1): 183-189.
4Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep, 1973, 4(2): 31-42.
5Kalemkerian GP, Akerley W, Bogner P, et al. NCCN clinical practice guidelines in small cell lung cancer. Version 2.2012. http://www.nccn, org/ professionals/physician_gls/pdf/sclc.pdf. Retrieved 2011-07-25.
6Wolf M, Hone P, Hans K, et al. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC). The role of sex as a predictor for survival. BrJ Gancer, 1991, 63(6): 986-992.
7Rawson NS, Peto J. An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Kesearch. BrJ Cancer, 1990, 61(4): 597-604.
8Paesmans M, Sculier JP, Lecomte J, et al. Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer, 2000, 89(3): 523-533.
9Singh S, Parulekar W, Murray N, et al. Influence of sex on toxicity and treatment outcome in small-cell lung cancer. J Clin Oncol, 2005, 23(4): 850-856,.
10Cerny T, Blair V, Anderson H, et al. Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer, 1987, 39(2): 146-149.
10[1]Theophile K,Jonigk D,Kreipe H,et al.Amplification of mRNA from laser-microdissected single or clustered cells in formalin-fixed and paraffin-embedded tissues for application in quantitative real-time PCR.Diagn Mol Pathol,2008,17(2):101-106.
3Ballen KK,Colvin G,Dey BR,et al.Cellular immunotherapy for re-fractory cancer novel therapeutic strategies[J]. Exp Hematology,2005,33(12):1427-1435.
4Yu JB,Decker RH,Detterbeck FC,et al.Surveillance epidemiology and end results evaluation of the role of surgery for stageⅠ small cell lung cancer [J]. J Thorac Oncol,2010,5(2):215-219.
5Niu Q,Wang W,Li Y,et al.Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancie[J].Int Immunop harmacol,2011,11(4):449-456.